Clinical trial
Lamictal As Add on Treatment in Mixed States of Bipolar Disorder
NCT00223509 · The University of Texas Health Science Center at San Antonio, Other · Completed
Key facts
| NCT number | NCT00223509 |
|---|---|
| Title | Lamictal As Add on Treatment in Mixed States of Bipolar Disorder |
| Official title | Lamictal As Add on Treatment in Mixed States of Bipolar Disorder |
| Lead sponsor | The University of Texas Health Science Center at San Antonio, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Lamotrigine |
| Enrollment | 28 |
| Start date | Aug 1, 2005 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 20, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: